Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians.

Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Chew EY, Buring JE, Manson JE, Hennekens CH.

Arch Ophthalmol. 2001 Aug;119(8):1143-9.

PMID:
11483080
2.

Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians.

Christen WG, Manson JE, Glynn RJ, Gaziano JM, Chew EY, Buring JE, Hennekens CH.

Arch Ophthalmol. 2007 Mar;125(3):333-9.

3.

Aspirin use and risk of cataract in posttrial follow-up of Physicians' Health Study I.

Christen WG, Ajani UA, Schaumberg DA, Glynn RJ, Manson JE, Hennekens CH.

Arch Ophthalmol. 2001 Mar;119(3):405-12.

PMID:
11231774
5.

Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women.

Christen WG, Glynn RJ, Chew EY, Buring JE.

Ophthalmology. 2009 Dec;116(12):2386-92. doi: 10.1016/j.ophtha.2009.05.031. Epub 2009 Oct 7.

6.

Low-dose aspirin and risk of cataract and subtypes in a randomized trial of U.S. physicians.

Christen WG, Manson JE, Glynn RJ, Ajani UA, Schaumberg DA, Sperduto RD, Buring JE, Hennekens CH.

Ophthalmic Epidemiol. 1998 Sep;5(3):133-42.

PMID:
9805346
7.

Migraine and subsequent risk of stroke in the Physicians' Health Study.

Buring JE, Hebert P, Romero J, Kittross A, Cook N, Manson J, Peto R, Hennekens C.

Arch Neurol. 1995 Feb;52(2):129-34.

PMID:
7848119
8.

Final report on the aspirin component of the ongoing Physicians' Health Study.

Steering Committee of the Physicians' Health Study Research Group.

N Engl J Med. 1989 Jul 20;321(3):129-35.

9.

Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trial.

Ridker PM, Manson JE, Gaziano JM, Buring JE, Hennekens CH.

Ann Intern Med. 1991 May 15;114(10):835-9.

PMID:
2014943
10.
11.

Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.

Ikeda Y, Shimada K, Teramoto T, Uchiyama S, Yamazaki T, Oikawa S, Sugawara M, Ando K, Murata M, Yokoyama K, Ishizuka N.

JAMA. 2014 Dec 17;312(23):2510-20. doi: 10.1001/jama.2014.15690.

PMID:
25401325
12.

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.

Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.

N Engl J Med. 2005 Mar 31;352(13):1293-304. Epub 2005 Mar 7.

13.

A randomized trial of beta carotene and age-related cataract in US physicians.

Christen WG, Manson JE, Glynn RJ, Gaziano JM, Sperduto RD, Buring JE, Hennekens CH.

Arch Ophthalmol. 2003 Mar;121(3):372-8.

PMID:
12617708
14.

Issues in the early termination of the aspirin component of the Physicians' Health Study. Data Monitoring Board of the Physicians' Health Study.

Cairns J, Cohen L, Colton T, DeMets DL, Deykin D, Friedman L, Greenwald P, Hutchison GB, Rosner B.

Ann Epidemiol. 1991 Aug;1(5):395-405.

PMID:
1669520
15.

Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study.

Glynn RJ, Buring JE, Manson JE, LaMotte F, Hennekens CH.

Arch Intern Med. 1994 Dec 12-26;154(23):2649-57.

PMID:
7993148
16.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2001 Oct;119(10):1417-36. Erratum in: Arch Ophthalmol. 2008 Sep;126(9):1251.

17.

Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians.

Manson JE, Grobbee DE, Stampfer MJ, Taylor JO, Goldhaber SZ, Gaziano JM, Ridker PM, Buring JE, Hennekens CH.

Am J Med. 1990 Dec;89(6):772-6.

PMID:
2252045
18.

Low-dose aspirin and risks of cataract in a randomized trial of US physicians.

Seddon JM, Christen WG, Manson JE, Buring JE, Sperduto RD, Hennekens CH.

Arch Ophthalmol. 1991 Feb;109(2):252-5.

PMID:
1993037
19.

Body mass index and the incidence of visually significant age-related maculopathy in men.

Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ.

Arch Ophthalmol. 2001 Sep;119(9):1259-65.

20.

Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study.

Christen WG, Glynn RJ, Chew EY, Albert CM, Manson JE.

Arch Intern Med. 2009 Feb 23;169(4):335-41. doi: 10.1001/archinternmed.2008.574.

Supplemental Content

Support Center